As of Feb 21
| +0.62 / +9.73%|
The 3 analysts offering 12-month price forecasts for Sunesis Pharmaceuticals Inc have a median target of 7.00, with a high estimate of 8.00 and a low estimate of 3.00. The median estimate represents a +0.14% increase from the last price of 6.99.
The current consensus among 4 polled investment analysts is to Buy stock in Sunesis Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.